Glenview Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.7M | Buy |
442,787
+6,415
| +1% | +$168K | 0.15% | 119 |
|
|
2026
Q1 | $12.3M | Buy |
436,372
+1,453
| +0.3% | +$38.7K | 0.19% | 100 |
|
|
2025
Q4 | $10.8M | Sell |
434,919
-8,934
| -2% | -$225K | 0.17% | 114 |
|
|
2025
Q3 | $11.3M | Sell |
443,853
-20,981
| -5% | -$518K | 0.18% | 114 |
|
|
2025
Q2 | $11.3M | Sell |
464,834
-28,766
| -6% | -$671K | 0.2% | 104 |
|
|
2025
Q1 | $12.5M | Buy |
493,600
+73,070
| +17% | +$1.91M | 0.24% | 100 |
|
|
2024
Q4 | $11.2M | Sell |
420,530
-100,525
| -19% | -$2.73M | 0.21% | 100 |
|
|
2024
Q3 | $15.1M | Buy |
521,055
+238
| +0% | +$6.94K | 0.29% | 82 |
|
|
2024
Q2 | $14.6M | Buy |
520,817
+33,979
| +7% | +$935K | 0.29% | 81 |
|
|
2024
Q1 | $13.5M | Buy |
486,838
+46,912
| +11% | +$1.3M | 0.29% | 84 |
|
|
2023
Q4 | $12.7M | Sell |
439,926
-125,509
| -22% | -$3.79M | 0.31% | 83 |
|
|
2023
Q3 | $18.8M | Buy |
565,435
+12,071
| +2% | +$427K | 0.52% | 54 |
|
|
2023
Q2 | $20.3M | Buy |
553,364
+3,766
| +0.7% | +$147K | 0.55% | 50 |
|
|
2023
Q1 | $22.4M | Buy |
549,598
+18,657
| +4% | +$806K | 0.67% | 39 |
|
|
2022
Q4 | $27.2M | Buy |
530,941
+14,110
| +3% | +$676K | 0.9% | 32 |
|
|
2022
Q3 | $22.6M | Buy |
516,831
+5,476
| +1% | +$266K | 0.86% | 33 |
|
|
2022
Q2 | $26.8M | Buy |
511,355
+10,940
| +2% | +$557K | 0.98% | 26 |
|
|
2022
Q1 | $25.9M | Buy |
500,415
+23,447
| +5% | +$1.22M | 0.84% | 31 |
|
|
2021
Q4 | $28.2M | Buy |
476,968
+11,734
| +3% | +$581K | 0.93% | 28 |
|
|
2021
Q3 | $20M | Buy |
465,234
+12,146
| +3% | +$538K | 0.77% | 40 |
|
|
2021
Q2 | $17.7M | Buy |
453,088
+36,986
| +9% | +$1.44M | 0.69% | 48 |
|
|
2021
Q1 | $15.1M | Buy |
416,102
+29,749
| +8% | +$1.06M | 0.65% | 51 |
|
|
2020
Q4 | $14.2M | Sell |
386,353
-19,445
| -5% | -$713K | 0.66% | 49 |
|
|
2020
Q3 | $14.1M | Buy |
405,798
+1,824
| +0.5% | +$63.9K | 0.73% | 41 |
|
|
2020
Q2 | $12.5M | Buy |
403,974
+34,675
| +9% | +$1.18M | 0.71% | 42 |
|
|
2020
Q1 | $11.4M | Buy |
369,299
+14,801
| +4% | +$504K | 0.79% | 38 |
|
|
2019
Q4 | $13.2M | Sell |
354,498
-31,884
| -8% | -$1.14M | 0.74% | 41 |
|
|
2019
Q3 | $13.2M | Buy |
386,382
+7,984
| +2% | +$290K | 0.8% | 38 |
|
|
2019
Q2 | $15.6M | Buy |
378,398
+18,388
| +5% | +$730K | 0.97% | 29 |
|
|
2019
Q1 | $14.5M | Buy |
360,010
+38,372
| +12% | +$1.54M | 0.93% | 32 |
|
|
2018
Q4 | $13.3M | Buy |
321,638
+36,710
| +13% | +$1.52M | 0.98% | 29 |
|
|
2018
Q3 | $11.9M | Buy |
284,928
+17,288
| +6% | +$666K | 0.75% | 39 |
|
|
2018
Q2 | $9.21M | Buy |
267,640
+24,523
| +10% | +$838K | 0.69% | 41 |
|
|
2018
Q1 | $8.19M | Buy |
243,117
+31,285
| +15% | +$1.08M | 0.57% | 59 |
|
|
2017
Q4 | $7.28M | Buy |
211,832
+9,177
| +5% | +$313K | 0.5% | 68 |
|
|
2017
Q3 | $6.86M | Sell |
202,655
-3,398
| -2% | -$109K | 0.5% | 69 |
|
|
2017
Q2 | $6.57M | Sell |
206,053
-5,481
| -3% | -$173K | 0.51% | 72 |
|
|
2017
Q1 | $6.87M | Buy |
211,534
+9,028
| +4% | +$285K | 0.54% | 66 |
|
|
2016
Q4 | $6.24M | Buy |
+202,506
| New | +$6.18M | 0.52% | 68 |
|
|
2015
Q4 | $5.94M | Buy |
+193,813
| New | +$6.1M | 0.62% | 56 |
|
|
2014
Q4 | $5.88M | Buy |
+198,782
| New | +$5.7M | 0.63% | 56 |
|
|
2013
Q4 | $6.64M | Buy |
+228,594
| New | +$6.65M | 0.76% | 47 |
|
Other funds holding PFE
Glenview Trust's PFE Position: Q2 2026 in Review
Glenview Trust increased its Pfizer (PFE) stake by 1.5% in Q2 2026, buying an estimated $168K and bringing the position to 442,787 shares worth $10.7M. The position accounts for 0.15% of the portfolio, ranked #119.
Glenview Trust first reported a position in PFE in Q4 2013 and has held it in 42 quarters since. The position peaked at $28.2M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Glenview Trust held 442,787 shares of Pfizer worth $10.7M as of Q2 2026.
- Glenview Trust bought 6,415 Pfizer shares in Q2 2026, an estimated $168K.
- Pfizer made up 0.15% of Glenview Trust's portfolio in Q2 2026, its #119 holding.
- Glenview Trust first reported a position in Pfizer in Q4 2013 and has held it in 42 quarters since.
- Glenview Trust's Pfizer position peaked at $28.2M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.